Active, not recruitingPhase 3NCT04587908

A Phase 3 Study of TAS-205 in Patients With Duchenne Muscular Dystrophy（REACH-DMD）

Studying Duchenne muscular dystrophy

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Taiho Pharmaceutical Co., Ltd.
Principal Investigator
Taiho Pharmaceutical Co., Ltd.
Taiho Pharmaceutical Co., Ltd.
Intervention
TAS-205 [Ambulatory Cohort] [Non-ambulatory Cohort](drug)
Enrollment
104 enrolled
Eligibility
5 years · MALE
Timeline
2020 – 2027

Study locations (5)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04587908 on ClinicalTrials.gov

Other trials for Duchenne muscular dystrophy

Additional recruiting or active studies for the same condition.

See all trials for Duchenne muscular dystrophy →

← Back to all trials